key: cord-0850337-gjrq24on
authors: Ruiz-Salmerón, Rafael; Robles, Carlos; Ronquillo-Japón, María; Iglesias-Blanco, Manuel
title: TCT CONNECT-443 Less Invasive Approaches for Left Atrial Appendage Closure: Ready for a New Era
date: 2020-10-27
journal: Journal of the American College of Cardiology
DOI: 10.1016/j.jacc.2020.09.471
sha: 7f1d05621751f1ac9cb94e87784b79f05cb43c99
doc_id: 850337
cord_uid: gjrq24on

nan

BACKGROUND Several studies have reported an inverse volumeoutcomes relationship for patients undergoing invasive cardiac procedures. Whether a similar association exists for percutaneous left atrial appendage occlusion (LAAO) remains unknown.

January and December 2017 were identified in the Nationwide Readmissions Database. Hospitals were categorized into 3 groups based on tertiles of annual procedural volume: low (5 to 15 cases/year), medium (17 to 31 cases/year), and high (32 to 211 cases/year). Hospitals with fewer than 5 annual procedures were excluded. Multivariable hierarchical logistic regression analyses were performed to examine the impact of institutional volume on in-hospital predischarge outcomes. The primary outcome of interest was major adverse events defined as a composite of mortality, stroke/transient ischemic attack, bleeding/ transfusion, vascular complications, myocardial infarction, systemic embolization, and pericardial effusion/tamponade requiring pericardiocentesis or surgery.

The study included 5,949 procedures performed in 196 hospitals with a median annual procedure volume of 41 cases/year (interquartile range: 25 to 67). Low versus high hospital volume was associated with higher rates of major adverse events, stroke/transient ischemic attack, and bleeding/transfusion (Table) . On multivariable analysis, lower hospital volume was associated with higher rates of in-hospital major adverse events (medium vs. low, adjusted odds ratio: 0.69; 95% confidence interval: 0.46 to 1.04; p ¼ 0.08; high vs. low, adjusted odds ratio: 0.55; 95% confidence interval: 0.37 to 0.82; p ¼ 0.003).

Overall METHODS This multicenter (n ¼ 8) retrospective study included patients undergoing TTP between January 2018 and May 2020. The choice of the device, the pre-interventional workup, and the postdischarge anticoagulation/antiplatelet regimen were left at the discretion of the operators. Baseline, procedural, and post-interventional characteristics were collected in a standardized case report form. The primary endpoint was the occurrence of any stroke, systemic embolic event, or cardiovascular death at day 30 following the procedure.

RESULTS A total 1,206 patients underwent LAAO procedures during the study, including TTP in 31 patients (2.6%/median age: 80 [76 to 87] years; CHAD2S-VASC2 score: 5 [4 to 6]). The indications for LAAO were contraindication to long-term oral anticoagulation (94%) and recurrent stroke under anticoagulant therapy (6%). The LAA thrombus was identified prior to intervention in 81% and during intervention in 19% of the cases. The thrombus was distal and its length inferior to 50% of the global LAA depth in 73% of the cases. The thrombus identification during pre-intervention workup led to anticoagulation reintroduction in 10 patients (32%). Amulet and Watchman FLX devices were implanted in 25 and 6 cases, respectively (diameter: 25 [25 to 28] mm). No embolic protection device was used in any of the cases. Patients were discharged under antiplatelet therapy in 82% and short-term oral anticoagulation in 18%. The primary endpoint occurred in 1 patient (3%, 1 stroke leading to cardiovascular death). Bleeding Academic Research Consortium 2 and 3 hemorrhagic events were reported in 2 and 1 patient, respectively.

CONCLUSION TTP represents a minority of LAAO procedures but appears feasible and safe in the short-term. METHODS All patients who were hospitalized and underwent LAAO from October 2015 to December 2017 in the U.S. National Readmission Database were queried. The primary endpoint was major in-hospital adverse events during index hospitalizations. The secondary endpoints included surrogates of severe disability (mechanical ventilation and nonhome discharge), cost of hospitalization, and readmission rates and causes at 30 days. A propensity score matching model was applied to derive 2 matched groups for comparative outcomes analysis (women vs. men)

Despite the low overall mortality in both groups during the index hospitalization (0.2%), women had significantly higher odds of death compared with men (odds ratio: 3.1; 95% CI: 1.1 to 9.0; p ¼ 0.03) and a higher rate of major in

01), nonhome discharges (11.4% vs. 6.7%, p < 0.01), and 30-day readmission rate (10% vs. 8.6%, p ¼ 0.03). The most common cause of readmission was cardiac (24%) followed by bleeding (19%)